Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Biomx Inc

PHGE
Current price
0.81 USD +0.055 USD (+7.31%)
Last closed 0.78 USD
ISIN US09090D1037
Sector Healthcare
Industry Biotechnology
Exchange NYSE
Capitalization 13 035 301 USD
Yield for 12 month -78.03 %
1Y
3Y
5Y
10Y
15Y
PHGE
21.11.2021 - 28.11.2021

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel. Address: 22 Einstein Street, Ness Ziona, Israel, 7414003

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

-357 000 USD

Last Year

-134 000 USD

Current Quarter

-2 017 000 USD

Last Quarter

-88 000 USD

Current Year

-1 228 000 USD

Last Year

-2 654 000 USD

Current Quarter

-2 348 000 USD

Last Quarter

-317 000 USD

Key Figures PHGE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -27 712 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -32.65 %
PEG Ratio
Return On Equity TTM -121.29 %
Wall Street Target Price
Revenue TTM
Book Value -0.72 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.9 USD
Diluted Eps TTM -3.9 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PHGE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PHGE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 26.08.2024
Dividend Date

Stock Valuation PHGE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.2497
Price Book MRQ 6.5418

Financials PHGE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PHGE

For 52 weeks

0.62 USD 8.55 USD
50 Day MA 1.02 USD
Shares Short Prior Month 21 055
200 Day MA 2.53 USD
Short Ratio 0.73
Shares Short 26 481
Short Percent 0.17 %